BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16397577)

  • 1. NF-kappaB-related genetic diseases.
    Courtois G; Smahi A
    Cell Death Differ; 2006 May; 13(5):843-51. PubMed ID: 16397577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB and inflammation in genetic disease.
    Sebban H; Courtois G
    Biochem Pharmacol; 2006 Oct; 72(9):1153-60. PubMed ID: 16965764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the NF-kappaB signaling pathway: implications for human disease.
    Courtois G; Gilmore TD
    Oncogene; 2006 Oct; 25(51):6831-43. PubMed ID: 17072331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation.
    Li H; Lin X
    Cytokine; 2008 Jan; 41(1):1-8. PubMed ID: 18068998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zfra affects TNF-mediated cell death by interacting with death domain protein TRADD and negatively regulates the activation of NF-kappaB, JNK1, p53 and WOX1 during stress response.
    Hong Q; Hsu LJ; Schultz L; Pratt N; Mattison J; Chang NS
    BMC Mol Biol; 2007 Jun; 8():50. PubMed ID: 17567906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the regulator: NF-kappaB signaling in heart.
    Hall G; Hasday JD; Rogers TB
    J Mol Cell Cardiol; 2006 Oct; 41(4):580-91. PubMed ID: 16949095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
    Fan S; Meng Q; Laterra JJ; Rosen EM
    Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NF-kappaB signaling pathway in human genetic diseases.
    Courtois G
    Cell Mol Life Sci; 2005 Aug; 62(15):1682-91. PubMed ID: 15924263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of NF-kappaB by HDAC inhibitor apicidin through Sp1-dependent de novo protein synthesis: its implication for resistance to apoptosis.
    Kim YK; Lee EK; Kang JK; Kim JA; You JS; Park JH; Seo DW; Hwang JW; Kim SN; Lee HY; Lee HW; Han JW
    Cell Death Differ; 2006 Dec; 13(12):2033-41. PubMed ID: 16628233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The I{kappa}B kinase {beta}/nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression.
    Hikoso S; Yamaguchi O; Nakano Y; Takeda T; Omiya S; Mizote I; Taneike M; Oka T; Tamai T; Oyabu J; Uno Y; Matsumura Y; Nishida K; Suzuki K; Kogo M; Hori M; Otsu K
    Circ Res; 2009 Jul; 105(1):70-9. PubMed ID: 19478205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling to NF-kappaB by Toll-like receptors.
    Kawai T; Akira S
    Trends Mol Med; 2007 Nov; 13(11):460-9. PubMed ID: 18029230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation.
    Orange JS; Levy O; Geha RS
    Immunol Rev; 2005 Feb; 203():21-37. PubMed ID: 15661019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB: tumor promoter or suppressor?
    Perkins ND
    Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic dissection of antigen receptor induced-NF-kappaB activation.
    Li ZW; Rickert RC; Karin M
    Mol Immunol; 2004 Jul; 41(6-7):701-14. PubMed ID: 15220005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New lessons from old pathogens: what parasitic infections have taught us about the role of nuclear factor-kappaB in the regulation of immunity.
    Mason NJ; Artis D; Hunter CA
    Immunol Rev; 2004 Oct; 201():48-56. PubMed ID: 15361232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of NF-kappaB signaling pathways by proteomic approaches.
    Niederberger E; Geisslinger G
    Expert Rev Proteomics; 2010 Apr; 7(2):189-203. PubMed ID: 20377387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.